Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient

J Viral Hepat. 2001 Mar;8(2):154-8. doi: 10.1046/j.1365-2893.2001.00275.x.

Abstract

Variants of hepatitis B virus (HBV), with amino acid substitutions in the major antigenic "a" determinant of hepatitis B surface antigen (HBsAg), have been described mainly in vaccinated children. In the present study in addition to vaccinated children, we have investigated Chinese blood donors positive for anti-HBc alone, and a patient with continuing liver disease after interferon-induced seroconversion to anti-HBs. Variants were detected in two of four children with break-through infections. One child had a double mutation (P142S and G145R) and the other a G145A substitution. Three of seven anti-HBc positive Chinese blood donors had a T131I substitution, whilst the interferon-treated patient had a treble amino acid substitution (P142S, G145R and N146D). The present results indicate that HBsAg variants may exist in individuals other than vaccinated children.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Amino Acid Substitution
  • Blood Donors*
  • Child
  • Cloning, Molecular
  • Female
  • Genetic Variation
  • Hepatitis B / immunology*
  • Hepatitis B Surface Antigens / genetics*
  • Hepatitis B, Chronic / immunology
  • Hepatitis B, Chronic / prevention & control
  • Hepatitis B, Chronic / virology*
  • Humans
  • Interferon-alpha / therapeutic use*
  • Male
  • Molecular Sequence Data
  • Mutation
  • Vaccination

Substances

  • Hepatitis B Surface Antigens
  • Interferon-alpha